Literature DB >> 3607998

[Current serologic data on viral hemorrhagic fevers in the Central African Republic].

D M Meunier, E D Johnson, J P Gonzalez, M C Georges-Courbot, M C Madelon, A J Georges.   

Abstract

During the years 1984-1985, 1,528 serum samples were taken through out the CAR. Of these sera, 319 (20.8%) contained anti-Filoviridae antibodies (Ebola, Marburg). This figure is higher than those found in Cameroon, Sudan, Gabon and Zaïre. Three zones of the country are particularly exposed, the North-East where the population is in the contact with Sudan Ebola, the South-East where it is in contact with Zaïre Ebola, and the South-West where it is in contact with Sudan Ebola. The authors believe that there could exist either a Central African Ebola strain or an Ebola-Like less pathogenic virus which is responsible for cross reactions. Results concerning Rift Valley Fever virus, Congo virus and Lassa virus seem less interesting. However RVF and Congo strains were isolated.

Entities:  

Mesh:

Year:  1987        PMID: 3607998

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  8 in total

1.  Rift Valley fever virus seroprevalence in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Marc Souris; Christophe Paupy; Janusz Paweska; Cindy Padilla; Ghislain Moussavou; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

2.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

3.  Hotspot or blind spot? Historical perspectives on surveillance and response to epidemics in the Central African Republic.

Authors:  Pierre-Marie David; Emmanuel Nakouné; Tamara Giles-Vernick
Journal:  Int J Public Health       Date:  2020-02-12       Impact factor: 5.100

Review 4.  Invasion of Aedes albopictus (Diptera: Culicidae) into central Africa: what consequences for emerging diseases?

Authors:  Carine Ngoagouni; Basile Kamgang; Emmanuel Nakouné; Chistophe Paupy; Mirdad Kazanji
Journal:  Parasit Vectors       Date:  2015-03-31       Impact factor: 3.876

Review 5.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

Review 6.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

7.  A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.

Authors:  Luke Nyakarahuka; Ilana J Schafer; Stephen Balinandi; Sophia Mulei; Alex Tumusiime; Jackson Kyondo; Barbara Knust; Julius Lutwama; Pierre Rollin; Stuart Nichol; Trevor Shoemaker
Journal:  BMC Infect Dis       Date:  2020-07-01       Impact factor: 3.090

8.  High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Matthias Borchert; Janusz Paweska; Antoine Tshomba; Afongenda Afounde; Amayo Kulidri; Robert Swanepoel; Jean-Jacques Muyembe-Tamfum; Patrick Van der Stuyft
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.